Atmo胶囊评估胃肠传输时间:与SmartPill胶囊的比较
本研究在213例疑诊或确诊胃肠传输障碍患者中随机顺序吞服Atmo胶囊与SmartPill胶囊,比较胃排空时间(GET)和结肠传输时间(CTT)。Atmo胶囊与SmartPill胶囊的GET和CTT测量值强相关(GET R=0.74,CTT R=0.69,均P<.01),延迟GET和CTT识别一致率为84%,未报告严重器械不良事件。
要点
- Atmo胶囊与SmartPill胶囊的GET和CTT测量值强相关(R=0.74和R=0.69,均P<.01)。
- 延迟GET和CTT识别一致率为84%,GET敏感度68%、特异度91%,CTT敏感度83%、特异度85%。
- Atmo胶囊测量GET和CTT的性能与参考标准无线动力胶囊等效,未报告严重器械不良事件。
核心结论
- Atmo胶囊测量GET和CTT的性能与参考标准无线动力胶囊等效,强相关且器械一致性好,是评估胃肠传输的valid方法。
研究设计与样本
- 多中心研究,纳入213例有上消化道和/或下消化道动力障碍症状的患者,来自12个中心,随机顺序吞服Atmo胶囊和SmartPill胶囊。
- 获得177对GET测量和147对CTT测量,采用Spearman相关和Bland-Altman分析评估胃肠传输时间。
主要发现
- GET和CTT测量值强相关:GET R=0.74(P<.01),CTT R=0.69(P<.01),观察偏倚在延迟传输界值的10%以内。
- 38%的参与者中识别出延迟GET(68/177)和延迟CTT(56/147),两者识别一致率均为84%。
- 延迟GET识别敏感度68%、特异度91%;延迟CTT识别敏感度83%、特异度85%。
- 未报告严重器械不良事件。
关键数值与推荐
- 延迟GET定义为≥5小时,延迟CTT定义为≥59小时。
临床怎么用
- Atmo胶囊可用于评估胃肠传输时间,其测量GET和CTT的性能与参考标准无线动力胶囊等效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Wireless motility capsules (WMCs) can be used to assess gastrointestinal transit time to facilitate diagnosis and treatment of motility disorders. The Atmo Capsule is a novel WMC that measures gases (H2, CO2, O2) and temperature. We aimed to compare and evaluate the performance characteristics of the Atmo Capsule and the SmartPill Capsule (discontinued reference standard WMC) for measurement of gastric emptying time (GET) and colonic transit time (CTT) in patients with confirmed or suspected disordered gastrointestinal transit. METHODS: Patients with symptoms indicative of an upper and/or lower gastrointestinal motility disorder ingested the 2 WMCs in a random order. Gastrointestinal transit times were assessed using Spearman correlation and Bland-Altman analysis. Device agreement was assessed for delayed GET (≥5 hours) and CTT (≥59 hours). RESULTS: There were 213 participants from 12 sites, yielding 177 paired GET and 147 paired CTT measurements. The measurements for GET and CTT with the Atmo Capsule and SmartPill Capsule were strongly correlated (GET, R = 0.74, P < .01; CTT, R = 0.69, P < .01), and their observed biases were within 10% of the delayed transit margin. Both delayed GET (68/177) and CTT (56/147) were identified in 38% of participants, with 84% agreement for identification of both delayed GET (sensitivity 68%, specificity 91%) and CTT (sensitivity 83%, specificity 85%). No serious adverse device effects were reported. CONCLUSIONS: The performance characteristics of the Atmo Capsule for measurements of GET and CTT were equivalent to the reference standard WMC with a strong correlation and good device agreement. These results demonstrate that the Atmo Capsule is a valid method for evaluating gastrointestinal transit. CLINICALTRIALS: gov number, NCT05718505.
引用
- Kuo B, Lee AA, Abell T, et al. The Assessment of Gastrointestinal Transit by the Atmo Capsule: A Comparison With the SmartPill Capsule. Clin Gastroenterol Hepatol. 2025. PMID: 39889900. doi:10.1016/j.cgh.2024.12.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。